MyFinsight
Home
Blog
About
Contact
Download
Download image
Surgical
$380M
Pharmaceuticals
$2M
Vision Care
$2M
Pharmaceuticals
$52M
Vision Care
$11M
Revenue From Contract
With Customer...
$475M
Surgical
$225M
Vision Care
$266M
Other Revenues
$384M
Brandedand Other Generic
Products
$63M
Overthe Counter
Products
$475M
Device Products
$491M
Total revenues
$1,405M
Net loss
attributable to bausch + lomb...
-$58M
Interest income
$3M
Operating income
$112M
Total expenses
$1,293M
Net loss
-$58M
Loss before
provision for income taxes
$13M
Foreign exchange and
other
-$4M
Interest expense
$98M
Other expense, net
-$46M
Amortization of intangible
assets
$56M
Research and development
$94M
Selling, general and
administrative (note 3)
$564M
Cost of goods sold
(excluding amortization...
$1M
Cost of goods sold
(excluding amortization...
$507M
Provision for income taxes
$71M
Foreign tax rate
differences-DE
-$2M
Intercompany profit in ending
inventory-IE
-$4M
Capital loss on sale of
assets-IE
-$2M
Contingent consideration
fair value...
-$1M
Research & development
tax credits-US
$2M
Foreign tax rate
differences-US
-$1M
Expected provision for
income taxes at...
-$20M
Other-CA
$62M
Foreign exchange
impact-CA
$6M
Disallowed interest-CA
$1M
Non-deductible amount of
share-based compensation
$4M
Change in valuation
allowance-CA
$4M
Effects of cross-border
taxes-CA
$1M
Foreign tax rate
differences-Foreign Tax...
$2M
Other-DE
$1M
Change in valuation
allowance-NL
$1M
Foreign exchange
impact-IE
$1M
Disallowed interest-IE
$4M
Change in valuation
allowance-IE
$3M
Foreign tax rate
differences-IE
$12M
Other-US
$1M
Back
Back
Income Statement
source: myfinsight.com
Bausch & Lomb Corp (BLCO)
Bausch & Lomb Corp (BLCO)